Day two of ESMO and our IQVIA experts are waiting to talk to you. Head over to booth 503 to discuss the latest in oncology research and global trends in cancer care (Pictured, left to right: Ciara McCarthy, Director Business Development, Real World Solutions; Tamara Kovacevic, Business Development Manager, IQVIA Biotech; Kathy Kane, Senior Director Business Development, Research and Development Solutions) #ESMO24
IQVIA Research & Development Solutions
研究服务
Durham，NC 62,277 位关注者
Using intelligent connections to accelerate your clinical trials without compromise.
关于我们
IQVIA Research & Development Solutions (RDS) is the full-service clinical development partner that leverages the power of IQVIA Connected Intelligence across your entire study, from study design to site selection, enrollment and execution, so you can deliver life-changing therapies faster and without compromise.
- 网站
-
https://www.iqvia.com/solutions/research-and-development
IQVIA Research & Development Solutions的外部链接
- 所属行业
- 研究服务
- 规模
- 超过 10,001 人
- 总部
- Durham，NC
动态
-
Integrating rapid speed, superior accuracy and enhanced site support, IQVIA’s innovative Risk-Based Monitoring uses AI/ML algorithms to ensure optimal clinical trial management – helping you to go beyond expectations. Find out more about IQVIA's commitment to sustainable monitoring solutions. https://bit.ly/3zr3pT9 #RiskbasedMonitoring #AI #ML #clinicaltrials
-
-
What a great start to ESMO 2024! Our oncology experts Emily Brand, Colin Farquharson Matt Simmons and Marc Thevenin-Lemoine are excited to meet you at IQVIA booth 503. Stop by to say hello and find out how our teams can support your oncology program. #ESMO24 #oncology
-
-
“Through early engagement, we help plan out and perform assessments throughout the entire process. Only then can a safe and efficacious cell-based therapy reach the patients that need it.” Keeping track of the information collected by a CRO and central lab can be challenging. Here, IQVIA’s Diego Correa explains how we keep the process as smooth as possible. https://lnkd.in/gAGAeaMB #CAGT #cellbasedtherapy
-
-
IQVIA’s Risk-Based Validation uses dual programming selectively to redistribute focus where needed—enhancing timeline response, and empowering you with maximum quality submission. Download the fact sheet to learn more. https://bit.ly/3ziqnfq #riskbasedvalidation #FSP
-
-
This September, World Alzheimer's Month is shining a light on attitudes to dementia. On September 20, the publication of the World Alzheimer Report will seek to challenge the belief that dementia is a part of normal aging – redressing the stigma and discrimination that persists. Find out more about the positive steps being taken to develop a more dementia-friendly society. https://bit.ly/3XFdYv9 #TimeToActOnDementia #TimeToActOnAlzheimers #WorldAlzMonth
-
-
Discover how a holistic approach to RBQM enhances patient safety, data quality, and trial efficiency. Join our industry leaders for an insightful round table discussion on unlocking RBQM excellence. Register now. #RBQM #PatientSafety
此处无法显示此内容
在领英 APP 中访问此内容等
-
IQVIA Research & Development Solutions转发了
In ‘Navigating the Complex Oncology Landscape’ IQVIA Biotech’s Global Head of Oncology Gerhard du Toit outlines strategies for clinical trial success in an evolving oncology landscape. At this year’s ESMO Congress, you’ll have the chance to meet with Gerhard, and discuss your oncology drug development program. Learn more. https://bit.ly/3Zrljjc #ESMO2024
-
-
The EU CT Regulation was implemented in January 2022 and IQVIA teams have been leading sponsors through the challenges that this ground-breaking regulation has introduced. Many in the industry have been struggling to adapt to the changes that this has brought to the clinical trial landscape in the EU. IQVIA Regulatory and GSA teams have been on-hand to support our customers through the changes. https://bit.ly/3TpaHh8 #regulatory #clinicaltrials
-
-
If you missed our webinar on how to optimize study strategy through the right mix of comprehensive standards, E2E Data Flow, and Data Collection, it’s not too late to catch up! Watch now to discover how a strong study strategy can increase data transparency for faster decision-making and accelerated study start-up. https://bit.ly/3zicC0b #DataFlow #clinicalstudies
-